CMAJ study: Increased dosage of Tamiflu required in treating H1N1 influenza patients

Links shared publicly online about this topic.

1,376
total visits

CMAJ study: Increased dosage of Tamiflu required in treating H1N1 influenza patients

An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study http://www.cmaj.ca/cgi/doi/10.1503/cmaj.092127 in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

View full resource at news-medical.net

Tags: Flu, Flu Medication, H1N1, Disease and Condition, Tamiflu, News, Medical